Our results suggest that accounting for confounding variables (poststroke BP and LDL cholesterol levels in the primary analysis and APOE4 in the prespecified subgroup analysis) was necessary to detect the association between poststroke hyperglycemia and accelerated global cognitive decline. Here, APOE is linked to Hyperglycemia.